Age does not matter: the relevance of immediate instillation therapy with Mitomycin C in non-muscle invasive bladder cancer

Urothelial carcinoma is the second most common urological malignancy, and the majority of patients with this diagnosis are between the ages of 75 and 85. In most cases, patients initially present with non-muscle invasive bladder cancer (NMIBC), which accounts for about 70% of all diagnosed bladder carcinomas.